Literature DB >> 10986007

Dose-response relationships for induction of CYP1A1 and CYP1A2 enzyme activity in liver, lung, and skin in female mice following subchronic exposure to polychlorinated biphenyls.

M J DeVito1, M G Ménache, J J Diliberto, D G Ross, L S Birnbaum.   

Abstract

The Toxic Equivalency Factor (TEF) method is used to estimate potential health risks associated with exposure to dioxin-like chemicals. The TEF method is a relative potency (REP) scheme that assumes dose additivity, that the chemicals produce the same response through the same mechanism, and that the REP of a chemical is equivalent for all responses. The present study estimates the REP for five PCBs with dioxin-like activity. Mice were exposed to either 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 2,3,3',4, 4'-pentachlorobiphenyl (105), 2,3',4,4',5-pentachlorobiphenyl (118), 3,3',4,4',5-pentachlorobiphenyl (126), or 2,3,3',4,4'-, 5-hexachlorobiphenyl (156), five days/week for 13 weeks by oral gavage in a corn oil vehicle. Three days after the last dose, animals were euthanized and the ethoxyresorufin-O-deethylase activity was determined in liver, lung, and skin. Acetanilide-4-hydroxylase activity was determined in liver. In addition, liver and skin disposition of the chemicals were determined. REPs were estimated using a statistical method previously described (DeVito et al., Toxicol. Appl. Pharmacol.147, 267-280, 1997). For any given compound, the REP generally varied by less than a factor of four across endpoints when calculated based on an administered dose. However, typically there was one response for every chemical in which the REP was different by an order of magnitude or more from the other responses. There was some evidence that the REPs may be dose-dependent. While, in general, these data support the use of a single point estimate of the REP, the issue of dose-dependency requires targeted investigation. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10986007     DOI: 10.1006/taap.2000.9010

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  7 in total

1.  Parameterizing dose-response models to estimate relative potency functions directly.

Authors:  Gregg E Dinse; David M Umbach
Journal:  Toxicol Sci       Date:  2012-06-14       Impact factor: 4.849

Review 2.  The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds.

Authors:  Martin Van den Berg; Linda S Birnbaum; Michael Denison; Mike De Vito; William Farland; Mark Feeley; Heidelore Fiedler; Helen Hakansson; Annika Hanberg; Laurie Haws; Martin Rose; Stephen Safe; Dieter Schrenk; Chiharu Tohyama; Angelika Tritscher; Jouko Tuomisto; Mats Tysklind; Nigel Walker; Richard E Peterson
Journal:  Toxicol Sci       Date:  2006-07-07       Impact factor: 4.849

3.  Characterizing non-constant relative potency.

Authors:  Gregg E Dinse; David M Umbach
Journal:  Regul Toxicol Pharmacol       Date:  2011-05-13       Impact factor: 3.271

4.  Activation of aryl hydrocarbon receptor signaling by cotton balls used for environmental enrichment.

Authors:  Shelley A Tischkau; Motoko Mukai
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-07       Impact factor: 1.232

5.  In utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: effects on fetal and adult cardiac gene expression and adult cardiac and renal morphology.

Authors:  Andrea C Aragon; Phillip G Kopf; Matthew J Campen; Janice K Huwe; Mary K Walker
Journal:  Toxicol Sci       Date:  2007-11-01       Impact factor: 4.849

Review 6.  Evaluation of relative effect potencies (REPs) for dioxin-like compounds to derive systemic or human-specific TEFs to improve human risk assessment.

Authors:  Karin I van Ede; Majorie B M van Duursen; Martin van den Berg
Journal:  Arch Toxicol       Date:  2016-05-09       Impact factor: 5.153

7.  Comparison of intake and systemic relative effect potencies of dioxin-like compounds in female mice after a single oral dose.

Authors:  Karin I van Ede; Patrik L Andersson; Konrad P J Gaisch; Martin van den Berg; Majorie B M van Duursen
Journal:  Environ Health Perspect       Date:  2013-05-03       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.